Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Torsten Kessler

8PUBLICATIONS
67CO-AUTHORS
Solid tumoursEpidemiological methodsAdolescent healthMolecular targetsData quality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Jan 20, 2026
Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS).

Stefan S Bielack, Dimosthenis Andreou, Daniel Baumhoer

|Oct 16, 2023
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.

Raphael Koch, Lianne Haveman, Ruth Ladenstein

|Apr 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.

Raphael Koch, Hans Gelderblom, Lianne Haveman

|Feb 15, 2022
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia.

Daniela V Wenge, Klaus Wethmar, Corinna A Klar

|Jul 02, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.

Andrew F Berdel, Christian Schwöppe, Caroline Brand

|Jun 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.

Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow

Pageof 2

Frequent Collaborators

3 joint publications

Daniel Baumhoer

2 joint publications

Anna Raciborska

2 joint publications

Peter Hauser

2 joint publications

Lianne Haveman

2 joint publications

Hauke Heinzow

2 joint publications

Torben Ek

2 joint publications

Andrew F Berdel

2 joint publications

Benedicte Brichard

2 joint publications

Hans Gelderblom

2 joint publications

Raphael Koch

Frequent Collaborators

3 joint publications

Daniel Baumhoer

2 joint publications

Anna Raciborska

2 joint publications

Peter Hauser

2 joint publications

Lianne Haveman

Top Related Videos

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on : Jun 13, 2018

9.3K
<em>In Vivo</em> Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

<em>In Vivo</em> Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on : Dec 09, 2016

12.5K
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

12.1K
See more related videos

Top Related Videos

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on : Jun 13, 2018

9.3K
<em>In Vivo</em> Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

<em>In Vivo</em> Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on : Dec 09, 2016

12.5K
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

12.1K
See more related videos